Form 4: Tenet Healthcare EVP Paola M. Arbour Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Filing Form 4


Paola M. Arbour, EVP and Chief Information Officer of Tenet Healthcare Corp, reports the acquisition of 5,605 restricted stock units.

Summary

  • Paola M. Arbour, an Executive Vice President and Chief Information Officer at Tenet Healthcare Corp, filed a Form 4 on March 1, 2024, with the SEC.
  • The report details a transaction on February 28, 2024, where Ms. Arbour acquired 5,605 restricted stock units (RSUs) of Tenet Healthcare Corp.
  • These RSUs vest in one-third increments annually over three years from the grant date and will be settled in shares of the company's common stock upon vesting.
  • Following this transaction, Ms. Arbour directly owns 5,605 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by an executive generally indicates confidence in the company's future, but it's a routine transaction.

Positives

  • The acquisition of restricted stock units by a high-ranking executive signals confidence in the company's future performance.

Future Outlook

The restricted stock units vest in one-third increments on each of the first, second and third anniversaries of the date of grant, indicating a multi-year incentive structure.

Industry Context

Executive compensation through stock and equity grants is a common practice in the healthcare industry to align management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock-based compensation is a standard practice among publicly traded healthcare companies like HCA Healthcare, Universal Health Services, and Community Health Systems.
  • The vesting schedule of one-third annually over three years is a typical vesting structure for restricted stock units in executive compensation packages.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.

Key Dates

DateDescription
02/28/2024Date of transaction: Acquisition of restricted stock units.
03/01/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.